ProspectiveTrial of Proton Beam Combined With Anti-VEGF Therapy for Exudative Age-related Macular Degeneration (AMD)
Status:
Completed
Trial end date:
2017-01-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to test the hypothesis that proton beam irradiation combined
with intravitreal anti-VEGF therapy is safe and potentially more effective than intravitreal
anti-VEGF therapy alone in eyes with exudative age-related macular degeneration.